Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05991687 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Methods for Effective Disposal of Surplus Analgesics to Facilitate Elimination

Study acronym: MEDSAFE
StatusCompleted
PhaseNot applicable
Started2023-07-31
View on ClinicalTrials.gov ↗

Amendment history

2026-09-04
Study Status, Study Design, Contacts/Locations v6
Trial completed
Final enrollment: 200 participants (planned 100)
Primary completion dateestimated 2026-08→confirmed 2026-09-04
Completion dateestimated 2026-08→confirmed 2026-09-04
Enrollment targetestimated 100→confirmed 200
Study sitesdetails revised at 1 of 1 site
2026-03-10
Study Status, Oversight, IPDSharing v5
Primary completion date2027-06→2026-08
Completion date2027-06→2026-08
2025-06-10
Study Status v4
Primary completion date2025-06→2027-06
Completion date2025-06→2027-06
2024-10-31
Study Status, Sponsor/Collaborators, Oversight, Contacts/Locations, IPDSharing v3
Primary completion date2024-11→2025-06
Completion date2024-11→2025-06
2024-02-06
Study Status v2
Primary completion date2024-03→2024-11
Completion date2024-03→2024-11
2023-09-11
Not Yet Recruiting→Recruiting Study Identification, Study Status, Sponsor/Collaborators, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2023-09→2024-03
Completion date2023-09→2024-03
Start dateestimated 2023-08-01→confirmed 2023-07-31
Study sitesdetails revised at 1 of 1 site
Collaborators+48 characters
Michigan Department of Health and Human Services
2023-08-07
Original filing
The primary objective is to evaluate the difference in outcomes for mail-in vs. in-home disposal methods for leftover prescription opioids after discharge from surgery.
Trial Details
NCT Number NCT05991687
Lead Sponsor University of Michigan
Collaborators: Michigan Department of Health and Human Services
Conditions Surgery, Analgesics, Opioids
Enrollment 200 participants
Start Date 2023-07-31
Primary Completion 2026-09-04 (estimated)
Study Completion 2026-09-04 (estimated)
Updated on ClinicalTrials.gov 2026-09-10